Tox21 Prepares to Launch Phase II of Chemical Screening Effort | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – A federal trans-agency initiative focused on using large-scale genomics, bioinformatics, and other technologies to predict how chemicals found in drugs, consumer, and industrial products, as well as food additives, will affect the human body and the environment has completed its first testing phases and now is moving on to begin screening a total of 10,000 chemicals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.